Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Reach for the sky

General

A building project to extend the Kennedy Institute of Rheumatology building with a new floor will create much needed space for the Institute to expand, particularly in the areas of data science and clinical trials.

Kennedy Professor leads Cellular Life Theme of Reuben College

Professor Mark Coles was recently appointed to the governing body of the University’s newest graduate college.

Joint cell discovery offers new hope for people with rheumatoid arthritis

The key to swift treatments to cure the pain of rheumatoid arthritis has been found in the joints of people with the condition who are in long- term remission.

Sir Marc Feldmann awarded the 2020 Tang Prize in Biopharmaceutical Science

Awards

Recognised for the part he played in the discovery of anti-TNF therapy, Dr Feldmann is now exploring whether the antibody can be effective for COVID-19.

NDORMS professor awarded prestigious Carol Nachman prize for Rheumatology

Awards

Christopher Buckley, Kennedy Professor of Translational Rheumatology at the University of Oxford and Birmingham, has been awarded the 2020 Carol Nachman prize for Rheumatology.

Oxford leads part of major COVID-19 drugs trial

The Arthritis Therapy Acceleration Programme (A-TAP), led by the Kennedy Institute in Oxford and the Institute of Inflammation and Ageing in Birmingham, provides support for the new CATALYST Trial to investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death.

New atlas of stromal cells maps out potential for treating human fibrosis

Research at the Kennedy Institute reveals sub-populations of stromal cells with distinct functions in human fibrotic disease. These findings could inform development of more specific therapies with fewer off-target effects.

Understanding of inflammatory bowel disease moves a step closer

Research

Published in Science Immunology, researchers at the Kennedy Institute have identified the role of IRF5 in controlling intestinal inflammation.

Dr. Michael Dustin joins Strategic Research Collaboration with Cue Biopharma

The research will test innovative technology that harnesses the body’s intrinsic immune system to transform the treatment of cancer and autoimmune diseases.

New weapon identified in arsenal against disease

Researchers in the Dustin Group reveal supramolecular attack particles are autonomous killing entities released from cytotoxic T lymphocytes

The NDORMS response to COVID-19

A number of members of the department are actively helping with the response to the COVID pandemic. Playing a key role in research, literature reviews, clinical trials and engineering projects, all have a shared commitment to collaborate globally to tackle the pandemic.

Professor Fiona Powrie elected to the National Academy of Sciences in the USA.

Department

Fiona was recognised for her outstanding contributions to immunology, and her election brings the number of current National Academy of Sciences members from the Kennedy Institute to three.

Live imaging shows surprising passage of T cells in the spleen

Research from Tal Arnon’s group at the Kennedy Institute reveals a network of perivascular pathways that guide T cells into the spleen.

Coronavirus information - what we are doing at NDORMS to support our staff and students and the community

Department

NDORMS announces the closure of the Kennedy and Botnar Institutes and outlines other plans and activities for the department during the pandemic.

Researchers identify markers in joint fluid that could be the key to cartilage repair

General Research

Molecular changes in the joint fluid during surgical joint distraction reveal markers that may drive cartilage repair in osteoarthritis.

CRUK success for NDORMS researchers

Funding

Investigators based at the Kennedy Institute of Rheumatology, NDORMS have recently received CRUK awards to increase understanding of a variety of cancers and immunotherapy.

Two new Associate Professors at NDORMS

Dr Fiona Watt and Professor Stephanie Dakin announced as Associate Professors

New collaboration will help researchers understand why cancer survival between patients differs

NDORMS researchers join five other universities to investigate how cancer survivors make antibodies that target and destroy tumours, and explore routes for new treatments

Load More